Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies-Reference-Cited by-同舟云学术

Characterizing inclusion and exclusion criteria in clinical trials for chimeric antigen receptor (CAR) T-cell therapy among adults with hematologic malignancies

Published:2021-03 Issue:2 Volume:12 Page:235-238
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Jaggers Jordon L.,Giri Smith,Klepin Heidi D.,Wildes Tanya M.,Olin Rebecca L.,Artz Andrew,Wall Sarah,Jaglowski Samantha,William Basem,Benson Don M.,Rosko Ashley E.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference14 articles.

1. Primary results from ZUMA-1: a pivotal trial of axicabtagene ciloleucel (axicel; KTE-C19) in patients with refractory aggressive non-Hodgkin lymphoma (NHL);Locke;Cancer Res,2017

2. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

3. Tisagenlecleucel in children and young adults with B-cell lymphoblastic Leukemia;Maude;N Engl J Med,2018

4. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells;Lee;Biol Blood Marrow Transplant,2019

5. Progress through collaboration: an ASCO and U.S. Food and Drug Administration workshop to improve the evidence base for treating older adults with cancer;Singh;Am Soc Clin Oncol Educ Book,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review;Journal of Geriatric Oncology;2024-04

2. Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysis;Journal of Geriatric Oncology;2023-09

3. How can Cytokine-induced killer cells overcome CAR-T cell limits;Frontiers in Immunology;2023-08-22

4. Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review;European Journal of Haematology;2023-06-29

5. Recent Advances in the Use of Chimeric Antigen Receptor–Expressing T-Cell Therapies for Treatment of Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2023-01